Get started
Author

Alyssa M. Greenwell

Observed names: Alyssa Greenwell, Alyssa M Greenwell
ORCID: 0000-0002-4867-5002
Observed ORCID: 0000-0002-4867-5002
OpenAlex ID: A5063673771
Lorlatinib for the Treatment of ALK Fusion–Positive Infant-Type Hemispheric Glioma: A Case Report
2022 · Alyssa M. Greenwell, Scott Baughan, et al. · JCO Precision Oncology · 6
Prolonged School Closure and Pediatric Respiratory Hospitalization: The Silver Lining of the COVID-19 Pandemic
2024 · Ali J. Bazzi, Zahur Fatima Sallman, et al. · Global Pediatric Health · 2
Inborn Errors of Immunity and Hematopoietic Cell Transplantation: Recognition and Pretransplant Management
2026 · Alyssa M. Greenwell, Avanti Gupte, et al. · Pediatric Annals · 1
Hgg-09. Contrasting Clinical Courses of Three Pediatric Patients With Pdgfra Amplified Radiation-induced High-grade Glioma
2024 · Alyssa M Greenwell, Kanta Bhambhani, et al. · Neuro-Oncology · 1
Isotretinoin‐induced psychosis in a child on treatment for high‐risk neuroblastoma
2022 · Alyssa M. Greenwell, Hamza S. Gorsi · Pediatric Blood & Cancer · 1
The Role of STAG2, CDKN2A, and TP53 Genes in Ewing Sarcoma: A Report of a Rare Case of Primary Ewing Sarcoma of the Kidney With Favorable Outcome
2026 · Alyssa M. Greenwell, Avanti Gupte, et al. · Journal of Pediatric Hematology/Oncology
Unique Features of Bone Marrow Mesenchymal Stromal Cells in Shwachman-Diamond Syndrome and the Effect of Allogeneic Hematopoietic Stem Cell Transplantation
2026 · Alyssa M Greenwell, Matteo MazzellaCandidate, et al. · Transplantation and Cellular Therapy
Effectiveness of a Streamlined Educational Experience: Improving Resident Medical Knowledge and Comfort Level in Pediatric Hematology and Oncology
2025 · Gianna G. Valenti, Alyssa M. Greenwell, et al. · Journal of Cancer Education
HGG-08. Lorlatinib for the treatment of ALK fusion positive infant high grade glioma
2022 · Alyssa Greenwell, Deniz Altinok, et al. · Neuro-Oncology
Works count: 9
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type